פריוויג'ן

Country: Израел

Језик: Хебрејски

Извор: Ministry of Health

Активни састојак:

IMMUNOGLOBULINS, NORMAL HUMAN

Доступно од:

CSL BEHRING LTD., ISRAEL

АТЦ код:

J06BA02

Фармацеутски облик:

תמיסה לאינפוזיה

Састав:

IMMUNOGLOBULINS, NORMAL HUMAN 100 G/L

Пут администрације:

תוך-ורידי

Тип рецептора:

מרשם נדרש

Произведен од:

CSL BEHRING AG, SWITZERLAND

Терапеутска група:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

Терапеутска област:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

Терапеутске индикације:

1. Replacement therapy in- Primary immunodeficiency syndromes such as:- Congenital agammaglobulinaemia and hypogammaglobulinaemia- Common variable immunodeficiency- Severe combined immunodeficiency- Wiskott-Aldrich syndrome- Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections-Children with congenital AIDS and recurrent infections2. Immunomodulation- Immune thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgical interventions to correct the platelet count-Guillain-Barr? syndrome- Kawasaki disease3. Allogeneic bone marrow transplantation

Датум одобрења:

2016-06-30